Cargando…

FANCM and RECQL genetic variants and breast cancer susceptibility: relevance to South Poland and West Ukraine

BACKGROUND: FANCM and RECQL have recently been reported as breast cancer susceptibility genes and it has been suggested that they should be included on gene panel tests for breast cancer predisposition. However, the clinical value of testing for mutations in RECQL and FANCM remains to be determined....

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen-Dumont, Tú, Myszka, Aleksander, Karpinski, Pawel, Sasiadek, Maria M., Akopyan, Hayane, Hammet, Fleur, Tsimiklis, Helen, Park, Daniel J., Pope, Bernard J., Slezak, Ryszard, Kitsera, Nataliya, Siekierzynska, Aleksandra, Southey, Melissa C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775547/
https://www.ncbi.nlm.nih.gov/pubmed/29351780
http://dx.doi.org/10.1186/s12881-018-0524-x
_version_ 1783293931877826560
author Nguyen-Dumont, Tú
Myszka, Aleksander
Karpinski, Pawel
Sasiadek, Maria M.
Akopyan, Hayane
Hammet, Fleur
Tsimiklis, Helen
Park, Daniel J.
Pope, Bernard J.
Slezak, Ryszard
Kitsera, Nataliya
Siekierzynska, Aleksandra
Southey, Melissa C.
author_facet Nguyen-Dumont, Tú
Myszka, Aleksander
Karpinski, Pawel
Sasiadek, Maria M.
Akopyan, Hayane
Hammet, Fleur
Tsimiklis, Helen
Park, Daniel J.
Pope, Bernard J.
Slezak, Ryszard
Kitsera, Nataliya
Siekierzynska, Aleksandra
Southey, Melissa C.
author_sort Nguyen-Dumont, Tú
collection PubMed
description BACKGROUND: FANCM and RECQL have recently been reported as breast cancer susceptibility genes and it has been suggested that they should be included on gene panel tests for breast cancer predisposition. However, the clinical value of testing for mutations in RECQL and FANCM remains to be determined. In this study, we have characterised the spectrum of FANCM and RECQL mutations in women affected with breast or ovarian cancer from South-West Poland and West Ukraine. METHODS: We applied Hi-Plex, an amplicon-based enrichment method for targeted massively parallel sequencing, to screen the coding exons and proximal intron-exon junctions of FANCM and RECQL in germline DNA from unrelated women affected with breast cancer (n = 338) and ovarian cancer (n = 89) from Poland (n = 304) and Ukraine (n = 123). These women were at high-risk of carrying a genetic predisposition to breast and/or ovarian cancer due to a family history and/or early-onset disease. RESULTS: Among 427 women screened, we identified one carrier of the FANCM:c.1972C > T nonsense mutation (0.23%), and two carriers of the frameshift insertion FANCM:c.1491dup (0.47%). None of the variants we observed in RECQL were predicted to be loss-of-function mutations by standard variant effect prediction tools. CONCLUSIONS: Our study of the Polish and Ukrainian populations has identified a carrier frequency of truncating mutations in FANCM consistent with previous reports. Although initial reports suggesting that mutations in RECQL could be associated with increased breast cancer risk included women from Poland and identified the RECQL:c.1667_1667 + 3delAGTA mutation in 0.23–0.35% of breast cancer cases, we did not observe any carriers in our study cohort. Continued screening, both in research and diagnostic settings, will enable the accumulation of data that is needed to establish the clinical utility of including RECQL and FANCM on gene panel tests. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12881-018-0524-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5775547
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57755472018-01-31 FANCM and RECQL genetic variants and breast cancer susceptibility: relevance to South Poland and West Ukraine Nguyen-Dumont, Tú Myszka, Aleksander Karpinski, Pawel Sasiadek, Maria M. Akopyan, Hayane Hammet, Fleur Tsimiklis, Helen Park, Daniel J. Pope, Bernard J. Slezak, Ryszard Kitsera, Nataliya Siekierzynska, Aleksandra Southey, Melissa C. BMC Med Genet Research Article BACKGROUND: FANCM and RECQL have recently been reported as breast cancer susceptibility genes and it has been suggested that they should be included on gene panel tests for breast cancer predisposition. However, the clinical value of testing for mutations in RECQL and FANCM remains to be determined. In this study, we have characterised the spectrum of FANCM and RECQL mutations in women affected with breast or ovarian cancer from South-West Poland and West Ukraine. METHODS: We applied Hi-Plex, an amplicon-based enrichment method for targeted massively parallel sequencing, to screen the coding exons and proximal intron-exon junctions of FANCM and RECQL in germline DNA from unrelated women affected with breast cancer (n = 338) and ovarian cancer (n = 89) from Poland (n = 304) and Ukraine (n = 123). These women were at high-risk of carrying a genetic predisposition to breast and/or ovarian cancer due to a family history and/or early-onset disease. RESULTS: Among 427 women screened, we identified one carrier of the FANCM:c.1972C > T nonsense mutation (0.23%), and two carriers of the frameshift insertion FANCM:c.1491dup (0.47%). None of the variants we observed in RECQL were predicted to be loss-of-function mutations by standard variant effect prediction tools. CONCLUSIONS: Our study of the Polish and Ukrainian populations has identified a carrier frequency of truncating mutations in FANCM consistent with previous reports. Although initial reports suggesting that mutations in RECQL could be associated with increased breast cancer risk included women from Poland and identified the RECQL:c.1667_1667 + 3delAGTA mutation in 0.23–0.35% of breast cancer cases, we did not observe any carriers in our study cohort. Continued screening, both in research and diagnostic settings, will enable the accumulation of data that is needed to establish the clinical utility of including RECQL and FANCM on gene panel tests. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12881-018-0524-x) contains supplementary material, which is available to authorized users. BioMed Central 2018-01-19 /pmc/articles/PMC5775547/ /pubmed/29351780 http://dx.doi.org/10.1186/s12881-018-0524-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Nguyen-Dumont, Tú
Myszka, Aleksander
Karpinski, Pawel
Sasiadek, Maria M.
Akopyan, Hayane
Hammet, Fleur
Tsimiklis, Helen
Park, Daniel J.
Pope, Bernard J.
Slezak, Ryszard
Kitsera, Nataliya
Siekierzynska, Aleksandra
Southey, Melissa C.
FANCM and RECQL genetic variants and breast cancer susceptibility: relevance to South Poland and West Ukraine
title FANCM and RECQL genetic variants and breast cancer susceptibility: relevance to South Poland and West Ukraine
title_full FANCM and RECQL genetic variants and breast cancer susceptibility: relevance to South Poland and West Ukraine
title_fullStr FANCM and RECQL genetic variants and breast cancer susceptibility: relevance to South Poland and West Ukraine
title_full_unstemmed FANCM and RECQL genetic variants and breast cancer susceptibility: relevance to South Poland and West Ukraine
title_short FANCM and RECQL genetic variants and breast cancer susceptibility: relevance to South Poland and West Ukraine
title_sort fancm and recql genetic variants and breast cancer susceptibility: relevance to south poland and west ukraine
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775547/
https://www.ncbi.nlm.nih.gov/pubmed/29351780
http://dx.doi.org/10.1186/s12881-018-0524-x
work_keys_str_mv AT nguyendumonttu fancmandrecqlgeneticvariantsandbreastcancersusceptibilityrelevancetosouthpolandandwestukraine
AT myszkaaleksander fancmandrecqlgeneticvariantsandbreastcancersusceptibilityrelevancetosouthpolandandwestukraine
AT karpinskipawel fancmandrecqlgeneticvariantsandbreastcancersusceptibilityrelevancetosouthpolandandwestukraine
AT sasiadekmariam fancmandrecqlgeneticvariantsandbreastcancersusceptibilityrelevancetosouthpolandandwestukraine
AT akopyanhayane fancmandrecqlgeneticvariantsandbreastcancersusceptibilityrelevancetosouthpolandandwestukraine
AT hammetfleur fancmandrecqlgeneticvariantsandbreastcancersusceptibilityrelevancetosouthpolandandwestukraine
AT tsimiklishelen fancmandrecqlgeneticvariantsandbreastcancersusceptibilityrelevancetosouthpolandandwestukraine
AT parkdanielj fancmandrecqlgeneticvariantsandbreastcancersusceptibilityrelevancetosouthpolandandwestukraine
AT popebernardj fancmandrecqlgeneticvariantsandbreastcancersusceptibilityrelevancetosouthpolandandwestukraine
AT slezakryszard fancmandrecqlgeneticvariantsandbreastcancersusceptibilityrelevancetosouthpolandandwestukraine
AT kitseranataliya fancmandrecqlgeneticvariantsandbreastcancersusceptibilityrelevancetosouthpolandandwestukraine
AT siekierzynskaaleksandra fancmandrecqlgeneticvariantsandbreastcancersusceptibilityrelevancetosouthpolandandwestukraine
AT southeymelissac fancmandrecqlgeneticvariantsandbreastcancersusceptibilityrelevancetosouthpolandandwestukraine